Inventor · disambiguated record
Mikko Unkila
Also filed as: UNKILA MIKKO
8 granted patents·3 pending applications·9 citations·filing 2001–2014
77Inventor score
Files withFORENDO PHARMA LTD3HORMOS MEDICAL CORP2HORMOS NUTRACEUTICAL OY LTD1JARVINEN TOMI1MESSINGER JOSEF1
Top patents by PatentIndex Score
11 records- 0170US8288367B2Substituted estratriene derivatives as 17BETA HSD inhibitorsMESSINGER JOSEF·Filed 2007·Granted Oct 16, 2012·2 cites·34 claims
- 0265US7008666B2Method of inhibiting overactivity of phagocytes or lymphocytes in an individualHORMOS NUTRACEUTICAL OY LTD·Filed 2001·Granted Mar 7, 2006·3 cites·1 claims
- 0359US7582677B2Lignan formulationsHORMOS MEDICAL CORP·Filed 2003·Granted Sep 1, 2009·2 cites·3 claims
- 0459US7524853B2Compounds and their use in therapySOLVAY PHARM BV·Filed 2004·Granted Apr 28, 2009·1 cites·40 claims
- 0553US7528166B2Lignan derivativesHORMOS MEDICAL CORP·Filed 2003·Granted May 5, 2009·1 cites·2 claims
- 0646US2005249857A1Lignan complexesJARVINEN TOMI·Filed 2003·Application pending·0 cites
- 0744US10377791B2Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1FORENDO PHARMA LTD·Filed 2014·Granted Aug 13, 2019·0 cites·16 claims
- 0843US9850272B2Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1FORENDO PHARMA LTD·Filed 2014·Granted Dec 26, 2017·0 cites·20 claims
- 0943US9663549B2Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenaseFORENDO PHARMA LTD·Filed 2014·Granted May 30, 2017·0 cites·24 claims
- 1043US2003144216A1Method for prevention of diseases in coeliac patientsFiled 2002·Application pending·0 cites
- 1137US2008057140A1Use of a Lignan for the Manufacture of a Composition for Preventing or Alleviating of Symptoms Relating to Estrogen DeficiencyUNKILA MIKKO·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mikko Unkila files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →